Nora Lee Cothran

1 month ago | optometrytimes.com | Nora Lee Cothran |Emily Kaiser Maharjan |Jordana Joy

March 20, 2025By Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment. Nora Lee Cothran, OD, FAAO, discussed a real-world study on switching glaucoma patients to latanoprostene bunod (LBN). Cothran explained that she initially noticed good pressure-lowering results when switching patients to LBN in her clinical practice.